Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2010-6-7
pubmed:abstractText
We explored multiple molecular mechanisms of the combination of docetaxel and an oncolytic prostate-restricted replication competent adenovirus (Ad) (PRRA) in advanced prostate cancer (PCa) models. The combinational therapy has potential to overcome the therapeutic limitations of poor virus distribution inside solid tumors.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1521-2254
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
516-27
pubmed:meshHeading
pubmed-meshheading:20527044-Adenoviridae, pubmed-meshheading:20527044-Animals, pubmed-meshheading:20527044-Antigens, CD29, pubmed-meshheading:20527044-Cell Death, pubmed-meshheading:20527044-Cell Line, Tumor, pubmed-meshheading:20527044-Enzyme Activation, pubmed-meshheading:20527044-Gene Expression Regulation, Neoplastic, pubmed-meshheading:20527044-Gene Therapy, pubmed-meshheading:20527044-Genes, Reporter, pubmed-meshheading:20527044-Genetic Vectors, pubmed-meshheading:20527044-Humans, pubmed-meshheading:20527044-Integrin beta3, pubmed-meshheading:20527044-Male, pubmed-meshheading:20527044-Neoplasm Transplantation, pubmed-meshheading:20527044-Promoter Regions, Genetic, pubmed-meshheading:20527044-Prostatic Neoplasms, pubmed-meshheading:20527044-Taxoids, pubmed-meshheading:20527044-Transgenes, pubmed-meshheading:20527044-Virus Replication, pubmed-meshheading:20527044-p38 Mitogen-Activated Protein Kinases
pubmed:year
2010
pubmed:articleTitle
Docetaxel increases antitumor efficacy of oncolytic prostate-restricted replicative adenovirus by enhancing cell killing and virus distribution.
pubmed:affiliation
Maine Institute for Human Genetics and Health, Bangor, ME, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural